XML 17 R4.htm IDEA: XBRL DOCUMENT v3.6.0.2
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Revenue:      
Product revenue $ 111,769 $ 77,389 $ 58,970
Development, service and licensing revenue 518 1,090 4,793
Total revenue 112,287 78,479 63,763
Cost of revenue:      
Cost of product revenue 52,614 37,360 29,003
Cost of development, service and licensing revenue 220 273 1,118
Total cost of revenue 52,834 37,633 30,121
Gross profit 59,453 40,846 33,642
Operating expenses:      
Research and development expense 25,185 17,579 14,287
Sales and marketing expense 22,330 14,579 10,825
General and administrative expense 12,426 7,087 6,115
Offering costs     1,959
Total operating expenses 59,941 39,245 33,186
Income (loss) from operations (488) 1,601 456
Interest income (expense) and other income (expense), net:      
Interest expense (1,633) (1,208) (901)
Interest income and other income (expense), net 616 673 838
Total interest income (expense) and other, net (1,017) (535) (63)
Income (loss) before tax expense (1,505) 1,066 393
Income tax expense (168) (166) (96)
Net income (loss) (1,673) 900 297
Less: Accretion of preferred stock (6,258) (11,301) (11,301)
Net loss attributable to common stockholders $ (7,931) $ (10,401) $ (11,004)
Net loss per share attributable to common stockholders — basic and diluted $ (0.74) $ (2.67) $ (3.30)
Weighted-average shares used to compute net loss per share attributable to common stockholders — basic and diluted 10,778 3,893 3,338